Thymalin

Evidence Anchor

BioHarmony 5.9/10

Thymalin sits at Neutral because it pairs a genuinely intriguing, decades-deep immune-restoration signal, headlined by the 2 to 4 fold elderly mortality drop in Khavinson 2003, with an evidence base that no independent group has ever confirmed, wrapped in a grey-market bovine injectable. If you are drawn to the Khavinson bioregulator program, understand that the entire human case is single-source and unreplicated, can verify a clean source, and treat thymalin as an experiment rather than a proven therapy, it is a reasonable thing to explore. If you want defined, Western-trialed evidence behind your immune support, the data is not there, and a better-characterized option carries far less uncertainty. The two biggest real-world frictions are the unverifiable sourcing of a bovine biological and the injection-course burden. ✅ Best for: Researchers and longevity enthusiasts fascinated by the Khavinson peptide-bioregulator program who want to explore its immune pillar firsthand. Older adults with declining immune function, the population with the clearest mechanistic reason to respond. People who fully accept that the human evidence is single-source and unreplicated and will judge thymalin on their own response rather than the headline numbers. Anyone who can source a clean, properly handled bovine-derived injectable and is comfortable with intramuscular course dosing. Users who treat it as a once-or-twice-a-year experiment inside a broader stack, not a proven staple. ❌ Avoid if: You want defined, independently trialed evidence, since thymalin's human results have never been reproduced outside one program. You cannot verify sterility and source quality, because a grey-market bovine biological carries contamination, endotoxin, and theoretical bovine-tissue concerns that the molecule's own safety record does not cover. You have any active or suspected cancer, where immune and growth-axis modulation is best avoided without specialist guidance. You have a known sensitivity to bovine proteins, given the allergic-reaction risk. You are uneasy with intramuscular self-injection or with running an unapproved compound at all.

Read the full BioHarmony report

My score and my verdict: one signal of three, never the whole answer.